» Articles » PMID: 18292230

Akt and CHIP Coregulate Tau Degradation Through Coordinated Interactions

Abstract

A hallmark of the pathology of Alzheimer's disease is the accumulation of the microtubule-associated protein tau into fibrillar aggregates. Recent studies suggest that they accumulate because cytosolic chaperones fail to clear abnormally phosphorylated tau, preserving a pool of toxic tau intermediates within the neuron. We describe a mechanism for tau clearance involving a major cellular kinase, Akt. During stress, Akt is ubiquitinated and degraded by the tau ubiquitin ligase CHIP, and this largely depends on the Hsp90 complex. Akt also prevents CHIP-induced tau ubiquitination and its subsequent degradation, either by regulating the Hsp90/CHIP complex directly or by competing as a client protein with tau for binding. Akt levels tightly regulate the expression of CHIP, such that, as Akt levels are suppressed, CHIP levels also decrease, suggesting a potential stress response feedback mechanism between ligase and kinase activity. We also show that Akt and the microtubule affinity-regulating kinase 2 (PAR1/MARK2), a known tau kinase, interact directly. Akt enhances the activity of PAR1 to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 complex. Moreover, Akt1 knockout mice have reduced levels of tau phosphorylated at PAR1/MARK2 consensus sites. Hence, Akt serves as a major regulator of tau biology by manipulating both tau kinases and protein quality control, providing a link to several common pathways that have demonstrated dysfunction in Alzheimer's disease.

Citing Articles

The ameliorative potential of metformin against aluminum-induced neurotoxicity: Insights from in vitro studies.

Sanajou S, Yirun A, Demirel G, Erkekoglu P, Sahin G, Baydar T J Appl Toxicol. 2024; 45(2):245-255.

PMID: 39275926 PMC: 11738538. DOI: 10.1002/jat.4695.


Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP.

Nadel C, Pokhrel S, Wucherer K, Oehler A, Thwin A, Basu K Nat Commun. 2024; 15(1):7972.

PMID: 39266525 PMC: 11393453. DOI: 10.1038/s41467-024-52075-1.


Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.

Batko J, Antosz K, Miskow W, Pszczolowska M, Walczak K, Leszek J Int J Mol Sci. 2024; 25(6).

PMID: 38542375 PMC: 10970155. DOI: 10.3390/ijms25063401.


Role of MARK2 in the nervous system and cancer.

Lei Y, Zhang R, Cai F Cancer Gene Ther. 2024; 31(4):497-506.

PMID: 38302729 DOI: 10.1038/s41417-024-00737-z.


Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.

Kumar M, Quittot N, Dujardin S, Schlaffner C, Viode A, Wiedmer A Brain. 2024; 147(2):637-648.

PMID: 38236720 PMC: 10834235. DOI: 10.1093/brain/awad378.


References
1.
Dickey C, Dunmore J, Lu B, Wang J, Lee W, Kamal A . HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J. 2006; 20(6):753-5. DOI: 10.1096/fj.05-5343fje. View

2.
Nishimura I, Yang Y, Lu B . PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell. 2004; 116(5):671-82. DOI: 10.1016/s0092-8674(04)00170-9. View

3.
Owada Y, Utsunomiya A, Yoshimoto T, Kondo H . Expression of mRNA for Akt, serine-threonine protein kinase, in the brain during development and its transient enhancement following axotomy of hypoglossal nerve. J Mol Neurosci. 1997; 9(1):27-33. DOI: 10.1007/BF02789392. View

4.
Qian S, McDonough H, Boellmann F, Cyr D, Patterson C . CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature. 2006; 440(7083):551-5. PMC: 4112096. DOI: 10.1038/nature04600. View

5.
Dickey C, Kamal A, Lundgren K, Klosak N, Bailey R, Dunmore J . The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest. 2007; 117(3):648-58. PMC: 1794119. DOI: 10.1172/JCI29715. View